Story perspectives
Surge in Invasive Lobular Carcinoma Diagnoses Raises Concerns
10/9/2025
32 3
1 of 1
Story summary
- About 33,600 women will be diagnosed with invasive lobular carcinoma (ILC) this year.
- ILC incidence rose 2.8% annually from 2012–2021, outpacing other breast cancers.
- Seven-year survival is lower for ILC than IDC.
- The rise is fastest among Asian American and Pacific Islander women at 4.4% per year, with experts calling for more research.
- Symptoms include nipple inversion and breast dimpling.
